Trade Spotlight: How should you trade Hubtown, Thyrocare Tech, EID Parry, JSW Infrastructure, Rallis India, Piramal Enterprises and others on July 14?

Consolidation is expected to continue in the upcoming sessions until the frontline indices trade above their short-term moving averages. Below are some short-term trading ideas to consider.

Trade Spotlight: How should you trade HDFC AMC, Finolex Industries, Orient Cement, CESC, ITD Cementation and others on Thursday?

The consolidation in the market is expected to continue, with a focus on stock-specific action amid the earnings season. Below are some trading ideas for the near term.

As bull run on D-Street continues, here are top 10 ideas for next 3-4 weeks

This week, 18,650-18,700 is expected to be a crucial hurdle and, if the index decisively surpasses this area, then 18,800-19,000 levels can't be ruled out

Trade Spotlight | What should you do with Shilpa Medicare, Thyrocare Technologies, Suven Pharma on Monday?

Thyrocare Technologies rose nearly 2 percent to Rs 635 and formed bullish candle on the daily charts with long upper shadow, which resembles bullish Harami kind of pattern formation, which is bullish reversal pattern. The trading volume was high on the same day.

Trade Spotlight | What should you do with Shree Cements, Thyrocare Technologies, Schneider Electric Infrastructure on Friday?

Shree Cements jumped 5.5 points to 24,458 and formed robust bullish candlestick pattern on the daily charts with robust volumes, continuing uptrend for fourth consecutive session. The stock has seen a break out of long downward sloping resistance trend line adjoining September 15, 2021 and April 29, 2022.

Top 10 trading ideas for next 3-4 weeks as caution reigns ahead of weekly expiry

Given the expiry week, there could be volatility with also focus on global cues. If the index fails to sustain Friday's low of 17,710 then we can see further selling pressure, experts said.

Hot Stocks | Here is why you should bet on BPCL, Thyrocare Technologies in short term

The pragmatic strategy would be to stay light on positions and be stock-specific, said Sameet Chavan of Angel One

Small and mid-cap in ‘bear’ phase but these 5 stocks are looking attractive after fall

As of now, mid-cap index is in “correction” and the small cap is in “rally attempt” till it breaches its recent lows

Nifty to remain soft in near term; these 24 picks can give up to 168% return

Prabhudas Lilladher expects the Nifty to trade in a range of 9,640-10,500 in the near term.

Buy, Sell, Hold: 10 stocks are being tracked by analysts on February 5

Morgan Stanley has upgraded Ashok Leyland to Overweight from equal-weight and raised target price to Rs 151 from Rs 101.30 per share.

Budget 2018: Not sure where to invest post Budget? Top 20 winning stocks to buy

“On the overall basis, long-term capital gains tax doesn’t look dampening and revenue growth assumptions are looking realistic. Investors should focus on sectors/stocks having agri or rural theme. Escorts, Ashok Leyland, M&M, PI Inds and UPL will be positive,” Hemang Jani, Head Equity Sales & Advisory, Sharekhan told Moneycontrol.

Are you ignoring them? Top ten contra bets which are good long-term buys

The risk-to-reward ratio will be more favourable for stocks which have not attracted too much of interest which could be due to the sector or stock-specific reasons.

Problem with Sun Pharma may aggravate: Surajit Pal

Dilip Bhat positive on pharma sector

Dilip Bhat of Prabhudas Lilladher is positive on the pharma sector largely because of the growth factor and because of the profitabilities.

Prefer SBI, Britannia, Reliance Capital: Dilip Bhat

Dilip Bhat, Joint MD at Prabhudas Lilladher is of the view that one may prefer SBI, Britannia Industries, Reliance Capital and Thyrocare.

Here is why SP Tulsian is bullish on Ujjivan Financial

In an interview with CNBC-TV18, SP Tulsian, sptulsian.com, shares his views on the microfinance space and sugar stocks.